Black Diamond Therapeutics, Inc - stock earnings
BDTX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -19.4 million USD | ? USD |
| 2023Q3 | -23.0 million USD | ? USD |
| 2023Q2 | -19.2 million USD | ? USD |
| 2023Q1 | -20.2 million USD | ? USD |
| 2022Q4 | -17.1 million USD | ? USD |
| 2022Q3 | -20.6 million USD | ? USD |
| 2022Q2 | -22.3 million USD | ? USD |
| 2022Q1 | -24.9 million USD | ? USD |
| 2021Q4 | -25.9 million USD | ? USD |
| 2021Q3 | -35.1 million USD | ? USD |
| 2021Q2 | -34.4 million USD | ? USD |
| 2021Q1 | -30.3 million USD | ? USD |
| 2020Q4 | -22.6 million USD | ? USD |
| 2020Q3 | -17.9 million USD | ? USD |
| 2020Q2 | -14.6 million USD | ? USD |
| 2020Q1 | -12.1 million USD | ? USD |
| 2019Q4 | -9.9 million USD | ? USD |
| 2019Q3 | -9.3 million USD | ? USD |
| 2019Q2 | -12.3 million USD | ? USD |
| 2019Q1 | -3.8 million USD | ? USD |
| 2018Q4 | -3.1 million USD | ? USD |
| 2018Q3 | -2.4 million USD | ? USD |
BDTX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -82.4 million USD | ? USD |
| 2022 | -84.5 million USD | ? USD |
| 2021 | -123.2 million USD | ? USD |
| 2020 | -65.5 million USD | ? USD |
| 2019 | -41.1 million USD | ? USD |
| 2018 | -8.9 million USD | ? USD |
| 2017 | -4.6 million USD | ? USD |
BDTX
Price: $6.96
52 week price:
Earnings Per Share: -1.88 USD
P/E Ratio: -2.51
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 81500
Market Capitalization: 278.2 million